Charles River ▲ Sign in to save

• ▲ Mijke Visser

  Charles River Laboratories (Netherlands) Biochemistry, Genetics and Molecular Biology
  1.04k

  citations

  8

  h-index

  3

  Aachen papers
• ▲ Sipke Dijkstra

  National Institute for Public Health and the Environment Neuroscience
  808

  citations

  14

  h-index

  1

  Aachen papers
• ▲ Eva Kritikou

  Charles River Laboratories (Netherlands) Immunology and Microbiology
  807

  citations

  10

  h-index

  1

  Aachen papers
• ▲ Johnny Suijker

  Mimetas (Netherlands) Medicine
  534

  citations

  8

  h-index

  9

  Aachen papers
• ▲ Rhea van de Bospoort

  Charles River Laboratories (Netherlands) Neuroscience
  419

  citations

  8

  h-index

  2

  Aachen papers
• ▲ Laure Grand Moursel

  Charles River Laboratories (Netherlands) Medicine
  413

  citations

  11

  h-index

  2

  Aachen papers
• ▲ Ivette Boogaard

  Charles River Laboratories (Netherlands) Medicine
  175

  citations

  4

  h-index

  1

  Aachen papers
• ▲ Kimberly Lo

  Charles River Laboratories (Netherlands) Engineering
  174

  citations

  5

  h-index

  2

  Aachen papers
• ▲ Ana C. P. Correia

  Amsterdam University Medical Centers · Cancer Center Amsterdam Biochemistry, Genetics and Molecular Biology
  171

  citations

  6

  h-index

  1

  Aachen papers
• ▲ Annelieke Strijbosch

  Charles River Laboratories (Netherlands) Neuroscience
  58

  citations

  2

  h-index

  1

  Aachen papers
• ▲ Sara Compte-Sancerni

  Charles River Laboratories (Netherlands) · Queen Mary University of London Medicine
  20

  citations

  2

  h-index

  4

  Aachen papers
• ▲ Marta da Silva

  Charles River Laboratories (Netherlands) Agricultural and Biological Sciences
  10

  citations

  2

  h-index

  1

  Aachen papers

12 results

• Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington’s Disease Pathology

  2022 Journal of Medicinal Chemistry article Neuroscience Genetic Neurodegenerative Diseases Open access

  34

  citations
• Development of mAb-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validation

  2022 PLoS ONE article Neuroscience Genetic Neurodegenerative Diseases Open access

  8

  citations
• Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease

  2023 Journal of Medicinal Chemistry article Neuroscience Genetic Neurodegenerative Diseases Open access cited by 1 patent

  8

  citations

3 results